Sort
10,829 grants matching “car t”
Immunotoxin Therapy of Solid and Hematopoietic Tumors: Preclinical Studies
$3,096,310Ira Pastan · Division Of Basic Sciences - Nci · ZIA · FY2021 · CA
Adoptive cell therapy for malignant mesothelioma and other mesothelin expressing
$3,067,127Raffit Hassan · Division Of Basic Sciences - Nci · ZIA · FY2025 · CA
Controllable solid tumor immunotherapy based on a wireless thermos-activator
$3,036,844Yingxiao Wang · University Of Southern California · R01 · FY2025 · CA
Development of Recombinant Toxins to Treat Hematologic Malignancies
$3,020,282Robert Kreitman · Division Of Basic Sciences - Nci · ZIA · FY2025 · CA
NRT-HDR: Convergence at the Interfaces of Policy, Data Science, Environmental Science and Engineering to Combat the Spread of Antibiotic Resistance
$3,000,000Amy J Pruden · Virginia Polytechnic Institute And State University · · FY2021 · EDU
FMRG: Bio: Manufacturing Multi-dimensional Culture Systems with Integrated Measurement and Manipulation Technologies
$2,999,999Susan T Sharfstein · Suny At Albany · · FY2025 · ENG
NRT: Accelerating Transdisciplinary Training of an Oklahoma Workforce for the Artificial Intelligence and Quantum Revolution
$2,999,630Yingmei Liu · Oklahoma State University · · FY2025 · EDU
Mechanism and biological consequences of the nuclear receptor CAR activation
$2,990,301Masahiko Negishi · National Institute Of Environmental Health Sciences · Z01 · FY2008 · ES
Autologous chimeric antigen receptor engineered T cell immunotherapy for desensitization in patients awaiting kidney transplantation
$2,975,228Ali Naji · University Of Pennsylvania · U01 · FY2021 · AI
Autologous chimeric antigen receptor engineered T cell immunotherapy for desensitization in patients awaiting kidney transplantation
$2,975,228Ali Naji · University Of Pennsylvania · U01 · FY2022 · AI
Harnessing the Data Revolution to Enable Predictive Multi-scale Modeling across STEM
$2,965,563Keith S Promislow · Michigan State University · · FY2022 · EDU
Mechanisms and biological consequences of the nuclear receptor CAR activation
$2,962,553Masahiko Negishi · National Institute Of Environmental Health Sciences · ZIA · FY2012 · ES
Mitigating risk in a closed loop system by exercise detection and miniaturization
$2,943,303Peter G Jacobs · Oregon Health & Science University · DP3 · FY2013 · DK
Collective Intelligence, Knowledge Infrastructure, & High Performance Computing
$2,941,656Calvin A Johnson · Center For Information Technology · ZIH · FY2009 · CT
Bone Marrow Grafting and Cellular Therapy for Leukemia and Lymphoma
$2,936,016Robert S Negrin · Stanford University · P01 · FY2025 · CA
Cassette exons in neoplastic pro-B-cells: implications for immunotherapy
$2,931,750Andrei Thomas-Tikhonenko · Children'S Hosp Of Philadelphia · U01 · FY2018 · CA
Enhancing Chimeric Antigen Receptor T Cell Therapies for Hematologic Malignancies: Beyond CART 19
$2,897,444Carl H. June · University Of Pennsylvania · P01 · FY2017 · CA
(Attack)2: Genetic engineering of cellular and humoral immunity to cure HIV
$2,872,207Scott G Kitchen · University Of California Los Angeles · U19 · FY2020 · AI
Engineering T cells to Provide Durable Control of HIV-1 Replication
$2,871,467James L Riley · University Of Pennsylvania · U19 · FY2020 · AI
Enhancing Chimeric Antigen Receptor T Cell Therapies for HematologicMalignancies: Beyond CART 19
$2,863,199Carl H. June · University Of Pennsylvania · P01 · FY2025 · CA
(Attack)2: Genetic engineering of cellular and humoral immunity to cure HIV
$2,848,211Scott G Kitchen · University Of California Los Angeles · U19 · FY2024 · AI
(Attack)2: Genetic engineering of cellular and humoral immunity to cure HIV
$2,848,126Scott G Kitchen · University Of California Los Angeles · U19 · FY2023 · AI
(Attack)2: Genetic engineering of cellular and humoral immunity to cure HIV
$2,847,927Scott G Kitchen · University Of California Los Angeles · U19 · FY2021 · AI
(Attack)2: Genetic engineering of cellular and humoral immunity to cure HIV
$2,847,671Scott G Kitchen · University Of California Los Angeles · U19 · FY2022 · AI
Impact of CAR and Nrf2 dual activation on cyclophosphamide bioactivation and doxorubicin detoxification
$2,840,768Hongbing Wang · University Of Maryland Baltimore · R01 · FY2025 · CA